PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Intraosseous vancomycin infusion during total hip arthroplasty was feasible for timely delivery of ...
Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global ...
The following text summarizes information provided in the video. The medullary cavity is a highly vascular structure that functions as a noncollapsible vein capable of accepting a large volume of ...
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/03/16 -- Pyng Medical Corp. (TSX VENTURE: PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical ...
VALLEY COTTAGE, N.Y. – Future Market Insights delivers key insights on the global intraosseous infusion devices market in a new publication titled “Intraosseous Infusion Devices Market: Global ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results